南京醫藥(600713.SH):擬公開掛牌出租南京市秦淮區延齡巷27號房地產
格隆匯6月25日丨南京醫藥(600713.SH)公佈,公司擬以公開掛牌方式出租權屬於公司的南京市秦淮區延齡巷27號房地產。該處房地產基於評估基準日的首年租金的評估價值為711.55萬元(人民幣,下同),評估結果已經國資監管部門備案。出租總面積13,325.11平方米(以實際可租賃面積為準),租賃期限為13年(156個月,免租期為6個月,租賃期前三年均攤)。租金按季支付,租金單價前三年不變,第四年起開始遞增,每三年在上一年租金的基礎上遞增5%,13年租賃期的租金總收入預計為9,709.73萬元。最終交易價格及受讓方將根據公開掛牌結果予以確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.